Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome

Hormones

Volumn 8, Issue 2, 2009, Pages 111-116

  Pacak, Karel ^a   Eisenhofer, Graeme ^b   Ilias, Ioannis ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c HELENA VENIZELOU HOSPITAL   (Greece)

Author keywords

Multiple endocrine neoplasia; Paraganglioma; Pheochromocytoma; Positron emission tomography

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 6 FLUORODOPA F 18; CHROMOGRANIN A; CHROMOGRANIN B; FLUORODEOXYGLUCOSE F 18; METADRENALIN; NEUROPEPTIDE Y; PROTEIN RET; SOMATOSTATIN RECEPTOR; SUCCINATE DEHYDROGENASE; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; FLUORINE;

ANXIETY; CANCER DIAGNOSIS; CANCER GENETICS; CANCER LOCALIZATION; CARDIOVASCULAR DISEASE; CATECHOLAMINE BLOOD LEVEL; CELL DIFFERENTIATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAPHORESIS; DYSPNEA; GENE MUTATION; HEADACHE; HEART PALPITATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; KIDNEY FUNCTION; METABOLIC RATE; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; RARE DISEASE; REVIEW; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; TACHYCARDIA; TREMOR; VON HIPPEL LINDAU DISEASE; ADRENAL TUMOR; PATHOLOGY; SCINTISCANNING; SIPPLE SYNDROME;

ADRENAL GLAND NEOPLASMS; DIHYDROXYPHENYLALANINE; FLUORINE RADIOISOTOPES; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY;

EID: 69149093162     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1227     Document Type: Review

References (38)

1. Lack EE 1997 Developmental, physiologic and anatomic aspects of adrenal cortex and medulla. In: Tumors of the adrenal gland and extra-adrenal paraganglia. Washington, DC: Armed Forces Institute of pathology: 1-31.
2. Young WF, 2006 Paragangliomas: clinical overview. Ann N Y Acad Sci 1073: 21-29.
3. Pacak K, Lenders JWM, Eisenhofer G 2007 Current trend in genetics of pheochromocytoma. In: Pheochromocytoma: diagnosis, localization and treatment. Malden, MA: Blackwell, pp, 30-40.
4. Pacak K, Lenders JWM, Eisenhofer G 2007 Current trends in biochemical diagnosis of pheochromocytoma. In: Pheochromocytoma, diagnosis, localization and treatment. Malden, MA: Blackwell, pp, 72-92.
5. Pacak K, Lenders JWM, Eisenhofer G 2007 Clinical presentation of pheochromocytoma. In: Pheochromocytoma: diagnosis, localization and treatment. Malden, MA: Blackwell, pp, 8-29.
6. Kimura N, Miura Y, Nagatsu I, Nagura H, 1992 Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extraadrenal paraganlioma. Virchows Archiv A Pathol Anat 421: 25-32.
7. Law NW, Alfano L, 1987 Non-functioning retroperitoneal paraganlioma. J Royal Soc Med 80: 246-247.
8. Pacak K, Lenders JWM, Eisenhofer G 2007 Introduction. In: Pheochromocytoma diagnosis, localization and treatment. Malden, MA: Blackwell, pp, 1-2.
9. Mittendorf EA, Evans DB, Lee JE, Perrier ND, 2007 Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment. Hematol Oncol Clin North Am 21: 509-525. (Pubitemid 46843518)
10. Ross JH, 2000 Pheochromocytoma. Special considerations in children. Urol Clin North Am 27: 393-402.
11. Gimm O, Koch CA, Januszewicz A, Opocher G, Neumann HP, 2004 The genetic basis of pheochromocytoma. Front Horm Res 31: 45-60.
12. Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL, 2003 Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 95: 1196-1204. (Pubitemid 37069549)
13. Kaltsas GA, Papadogias D, Grossman AB, 2004 The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas). Front Horm Res 31: 61-75.
14. Frank-Raue K, Kratt T, Hoppner W, Buhr H, Ziegler R, Raue F, 1996 Diagnosis and management of pheochromocytomas in patients with multiple endocrine neoplasia type 2-relevance of specific mutations in the RET proto-oncogene. Eur J Endocrinol 135: 222-225. (Pubitemid 26284196)
15. Kaplan NM 2006 Pheochromocytoma with a Preface About Incidental Adrenal Masses. In: Kaplan's clinical hypertension. Philadelphia, PA: Lippincott, Williams & Wilkins, pp, 389-433.
16. Pacak K, Lenders JWM, Eisenhofer G 2007 Catecholamines and adrenergic receptors. In: Pheochromocytoma: diagnosis, localization and treatment. Malden, MA: Blackwell, pp, 41-71.
17. Eisenhofer G, Walther MM, Huynh TT, et al, 2001 Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab 86:1999-2008. (Pubitemid 32472911)
18. Young WF 2008 Pheochromocytoma and paraganglioma. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology. Philadelphia, PA: Saunders, pp, 507-521.
19. Cleary S, Phillips JK, Huynh TT, et al, 2007 Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome. J Endocrinol 193: 225-233.
20. Brouwers FM, Gläsker S, Nave AF, et al, 2007 Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B. Endocr Relat Cancer 14: 463-467. (Pubitemid 47242644)
21. Raber W, Raffesberg W, Bischof M, et al, 2000 Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch Intern Med 160: 2957-2963. (Pubitemid 32009053)
22. Lenders JW, Pacak K, Walther MM, et al, 2002 Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287: 1427-1434.
23. Sawka AM, Jaeschke R, Singh RJ, Young WF, 2003 A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88: 553-558. (Pubitemid 36207789)
24. Václavík J, Stejskal D, Lacnák B, et al, 2007 Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients. J Hypertens 25: 1427-1431. (Pubitemid 46918830)
25. Grossman A, Pacak K, Sawka A, et al, 2006 Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus? Ann N Y Acad Sci 1073: 332-347.
26. Eisenhofer G, Lenders JW, Pacak K, 2004 Biochemical diagnosis of pheochromocytoma. Front Horm Res 31:76-106.
27. Ilias I, Sadhev A, Reznek RH, Grossman AB, Pacak K, 2007 The optimal imaging of adrenal tumors: a comparison of different methods. Endocr Relat Cancer 14: 587-599. (Pubitemid 350074049)
28. Ilias I, Pacak K, 2004 Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 89: 479-491. (Pubitemid 38269845)
29. Jacques AE, Sahdev A, Sandrasagara M, et al, 2008 Adrenal phaechromocytoma: correlation of MRI appearances with histology and function. Eur Radiol 18: 2885-2892.
30. Zianni D, Tzanela M, Klimopoulos S, Thalassinos NC, 2004 Symptomatic pheochromocytoma with normal urinary catecholamine metabolites. Hormones (Athens) 3: 132-137.
31. Go AS 1998 Refining Probability: An Introduction to the Use of Diagnostic Tests. In: Friedland DJ, ed. Evidence-Based Medicine. New York, NY: McGraw-Hill, pp,12-33.
32. Shulkin BL, Ilias I, Sisson JC, Pacak K, 2006 Current trends in functional imaging of pheochromocytomas and paragangliomas. Ann N Y Acad Sci 1073: 374-382. (Pubitemid 44912032)
33. Van Der Horst-Schrivers AN, Jager PL, Boezen HM, Schouten JP, Kema IP, Links TP, 2006 Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas - experience and meta-analysis. Anticancer Res 26: 1599-1604.
34. Ilias I, Chen CC, Carrasquillo JA, et al, 2008 Comparison of 6-[18F]-fluorodopamine positron emission tomography to [123I]- metaiodobenzylguanidine and [111In]-pentetreotide scintigraphy in the localization of non-metastatic and metastatic pheochromocytoma. J Nucl Med 49: 1613-1619.
35. Ilias I, Yu J, Carrasquillo JA, et al, 2003 Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]- metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 88: 4083-4087. (Pubitemid 37153702)
36. Cleary S, Phillips JK, 2006 The norepinephrine transporter and pheochromocytoma. Ann N Y Acad Sci 1073: 263-269.
37. Kaji P, Carrasquillo JA, Linehan WM, et al, 2007 The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome. Eur J Endocrinol 156: 483-487. (Pubitemid 46672650)
38. Ilias I, Pacak K, 2008 A clinical overview of pheochromocytomas, paragangliomas and carcinoid tumors Nucl Med Biol 35: Suppl 1: 27-34.